Advertisement

Methods of Assessment of Antiepileptic Drugs

  • Norman Milligan
  • Alan Richens

Abstract

Epilepsy is a symptom with protean manifestations and as such it is a difficult disease in which to carry out a therapeutic trial. The methods available to research workers for the assessment of new antiepileptic drugs are hampered by the fact that epilepsy is a fluctuant condition. Although it is a chronic disorder open to study using cross-over trials and within-patient comparisons, accurate assessments cannot be easily made at any one point in time. Research workers are therefore automatically placed at a time factor disadvantage and this is especially so for those searching for quick methods of evaluating new compounds. The need for a quick and reliable method of assessing a new antiepileptic drug has long been appreciated. This article will discuss the methods currently available and we will begin by considering the most commonly used method of assessment with particular reference to some of the problems involved in conducting a controlled clinical trial in epilepsy.

Keywords

Epileptic Patient Absence Seizure Sodium Valproate Complex Partial Seizure Epileptic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. AHMAD, S., PERUCCA, E. & RICHENS, A. (1977). The effect of frusemide, mexiletine, (+) propranolol and three benzodiazepine drugs on interictal spike discharges in the electroencephalogram of epileptic patients. Br. J. clin. Pharmac., 4, 683–688.CrossRefGoogle Scholar
  2. ALTMAN, D.G. (1980). Statistics and ethics in medical research. Br. med. J., 281, 1336–1338.PubMedPubMedCentralCrossRefGoogle Scholar
  3. AMBROZ, A., CHALMERS, T.C., SMITH, H., SCHROEDER, B., FRIEMAN, J.A. & SHARECK, E.P. (1978). Deficiencies of randomised controlled trials. Clin. Res., 26, 280 A.Google Scholar
  4. BANCOUD, J., RIBET, M.F. & CHAGOT, D. (1975). Comparison between discharges of subclinical spikes and clinical epileptic attacks in patients with epilepsy. Electroencephalogr. clin. Neurophysiol., Soc. Proc. 39, 554.Google Scholar
  5. BINNIE, C.D. (1980). The use of the EEG in the diagnosis of the epilepsies. J. Electrophysiol. Technol, 6, 59–74.Google Scholar
  6. BIRKET-SMITH, E., LUND, M., MIKKELSEN, B., VESTER-MARK, S., ZANDER-OLSEN, P. & HULM, P. (1973). A controlled trial of Ro 5–4023 (clonazepam) in the treatment of psychomotor epilepsy. Acta neurol. Scand., 49, Suppl. 53, 18–25.Google Scholar
  7. BROWNE, T.R. & PENRY, J.K. (1973). Benzodiazepines in the treatment of epilepsy: A review. Epilepsia, 14, 277–310.PubMedCrossRefGoogle Scholar
  8. BROWNE, T.R., PENRY, J.K., PORTER, R.J. & DREIFUSS, F.E. (1974). Responsiveness before, during and after spike-wave paroxysms. Neurology (Minneap.), 7, 659–665.CrossRefGoogle Scholar
  9. BULPITT, C.J. (1975). The design of clinical trials. Br. J. Hosp. Med., 13,611–620.Google Scholar
  10. CARRIE, J.R.G. (1976). Computer assisted EEG sharp-transient detection and quantification during overnight recordings in an epileptic patient. In Quantitative Analytic Studies in Epilepsy, eds Kellerway, P. & Petersen, I. New York: Raven Press.Google Scholar
  11. CEREGHINO, J.J., BROCK, J., VAN METER, J., PENRY, J.K., SMITH, L. & WHITE, B. (1974). Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology (Minneap.), 24, 401–410.CrossRefGoogle Scholar
  12. CEREGHINO, J.J. & PENRY, J.K. (1972). General principles: testing of anticonvulsants in man. In Anti-epileptic Drugs, eds Woodbury, D.M., Penry, J.K. & Schmidt, R.P., pp. 63–73. New York: Raven Press.Google Scholar
  13. CEREGHINO, J.J., VAN METER, J., BROCK, J.T., PENRY, J.K., SMITH, L. & WHITE, B.G. (1973). Preliminary observations of serum carbamazepine concentration in epileptic patients. Neurology (Minneap.), 23, 357–366.CrossRefGoogle Scholar
  14. COVANIS, A. & JEAVONS, P.M. (1980). Once-daily sodium valproate in the treatment of epilepsy. Dev. Med. Child Neurol., 22,202–204.PubMedCrossRefGoogle Scholar
  15. GASTAUT, H. (1969). Classification of the epilepsies. Proposal for an international classification. Epilepsia, 10, Suppl. 514–521.Google Scholar
  16. GIBBS, F.A., DAVIS, H. & LENNOX, W.G. (1935). The electroencephalogram in epilepsy and in conditions of impaired consciousness. Arch. Neurol. Psychiatr., 34, 1133–1148.CrossRefGoogle Scholar
  17. GOODE, D.J., PENRY, J.K. & DREIFUSS, F.E. (1970). Effects on paroxysmal spike-wave activity on continuous visual-motor performance. Epilepsia, 11, 241–254.PubMedCrossRefGoogle Scholar
  18. GOTMAN, J., IVES, J.R. & GLOOR, P. (1979). Automatic recognition of inter-ictal epileptic activity in prolonged EEG recordings. Electroencephalogr. clin. Neuro-physiol., 46, 510–520.CrossRefGoogle Scholar
  19. GRAM, L., FLACHS, H., WÜRTZ-JORGENSEN, A., PARNAS, J. & ANDERSEN, B. (1979). Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia, 20, 303–312.PubMedCrossRefGoogle Scholar
  20. GRANT, R.H.E. & BAROT, N.H. (1976). The use of sodium valproate in severely handicapped patients with epilepsy. In Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, ed. Legg, N.J. pp. 14–22. Tunbridge Wells: MCS Consultants.Google Scholar
  21. GREEN, J.R. & KUPFERBERG, H.J. (1972). Sulthiame. In Antiepileptic Drugs, eds Woodbury, D.M., Penry, J.K. & Schmidt, R.P., pp. 477–485. New York: Raven Press.Google Scholar
  22. HALLIDAY, A.M. & MUSHIN, J. (1980). The visual evoked potential in neuro-ophthalmology. International Ophthalmology Clinics, 20, 155–183. Massachusetts: Little, Brown and Company.PubMedCrossRefGoogle Scholar
  23. HARDING, G.F.A., HERRICK, CE. & JEAVONS, P.M. (1978). A controlled study of the effect of sodium valproate on photosensitive epilepsy and its prognosis. Epilepsia, 19, 555–565.PubMedCrossRefGoogle Scholar
  24. HOUGHTON, G.W. & RICHENS, A. (1974a). Inhibition of phenytoin metabolism by sulthiame in epileptic patients. Br. J. clin. Pharmac., 1, 59–66.CrossRefGoogle Scholar
  25. HOUGHTON, G.W. & RICHENS, A. (1974b). Phenytoin intoxication induced by sulthiame in epileptic patients. J. Neurol. Neurosurg. Psychiat., 37, 275–281.PubMedPubMedCentralCrossRefGoogle Scholar
  26. ILAE COMMISSION ON ANTIEPILEPTIC DRUGS (1973). Principles for clinical testing of antiepileptic drugs. Epilepsia, 14,451–458.CrossRefGoogle Scholar
  27. IVES, J.R. & WOODS, J.F. (1975). 4-channel 24 hour cassette recorder for long term monitoring of ambulatory patients. Electroencephalogr. clin. Neurophysiol. 39, 88–92.PubMedCrossRefGoogle Scholar
  28. JEAVONS, P.M. & CLARK, J.E. (1974). Sodium valproate in treatment of epilepsy. Br. med. J., 2, 584–586.PubMedPubMedCentralCrossRefGoogle Scholar
  29. JEAVONS, P.M., CLARK, J.E. & MAHESHWARI, P. (1977). Treatment of generalised epilepsies of childhood and adolescence with sodium valproate (Epilim). Dev. Med. Child Neurol., 19,9–25.PubMedCrossRefGoogle Scholar
  30. JEAVONS, P.M. & HARDING, G.F.A. (1975). Photosensitive Epilepsy. A Review of the Literature and a study of 460 Patients. William Heinemann Books.Google Scholar
  31. KELLERWAY, P., FROST, J.D. Jr. & CRAWLEY, J.W. (1980). Time modulation of spike and wave activity in generalised epilepsy. Ann. Neurol., 8, 491–500.CrossRefGoogle Scholar
  32. KILLAM, K.F., KILLAM, E.K. & NAQUET, R. (1967). An animal model of light sensitive epilepsy. Electroencephalogr. clin. Neurophysiol., 22,497–513.PubMedCrossRefGoogle Scholar
  33. KILLAM, E.K., MATSUZAKI, M. & KILLAM, K.F. (1973). Studies of anticonvulsant compounds in the Papiopapio model of epilepsy. In Brain Function, ed. Sebelli, H.C., pp. 161–171. New York: Raven Press.Google Scholar
  34. LEE, S.I., MESSENHEIMER, J.A., WILKINSON, E.C., BRICKLEY, J.J. Jr. & JOHNSON, R.N. (1980). Visual evoked potentials to stimulus trains: normative data and application to photosensitive seizures. Electroencephalogr. clin. Neurophysiol., 48, 387–394.PubMedCrossRefGoogle Scholar
  35. LEVY, R., PITLICK, W., TROUPIN, A, GREEN, J. & NEAL, J. (1975). Pharmacokinetics of carbamazepine in normal man. Clin. Pharmac. Ther., 17, 657–668.Google Scholar
  36. LUBORSKY, L., DOCHERTY, J.P., TODD, T.C., KNAPP, P.H., MIRSKY, A.F. & GOTTSCHALK, L.A. (1975). A context of analysis of psychological states prior to petit mal EEG paroxysms. J. Nervous Mental Dis., 160, 282–298.CrossRefGoogle Scholar
  37. LÜCKING, C.H., CREUTZFELDT, O.D. & HEINEMANN, U. (1970). Visual evoked potentials of patients with epilepsy and a control group. Electroencephalogr. clin. Neurophysiol., 29, 557–566.PubMedCrossRefGoogle Scholar
  38. MARSDEN, C.D. (1975). Neurology. In A Textbook of Epilepsy, eds Laidlaw, J. & Richens, A. London and Edinburgh: Churchill Livingstone.Google Scholar
  39. MELDRUM, B.S., ANLEZARK, G., BALZAMO, E., HORTON, R.W. & TRIMBLE, M. (1975). Photically induced epilepsy in Papio papio as a model for drug studies. In Advances in Neurology, 10, eds Meldrum, B.S. & Marsden, C.D., pp. 119–132. New York: Raven Press.Google Scholar
  40. NEWMARK, M.E. & PENRY, J.K. (1979). Photosensitivity and Epilepsy: A Review. New York: Raven Press.Google Scholar
  41. PATEL, I.H., LEVY, R.H. & CUTLER, R.E. (1980). Phénobarbital—valproic acid interaction. Clin. Pharmac. Ther., 27, 515.CrossRefGoogle Scholar
  42. PENRY, J.K., PORTER, R.J. & DREIFUSS, F.E. (1971). Quantitation of paroxysmal abnormal discharges in the EEGs of patients with absence (petit-mal) seizures for the evaluation of antiepileptic drugs. Epilepsia, 12, 278–279.Google Scholar
  43. PORTER, R.J., PENRY, J.K. & DREIFUSS, F.E. (1973). Responsiveness at the onset of spike-wave bursts. Electroencephalogr. clin. Neurophysiol., 34,239–245.PubMedCrossRefGoogle Scholar
  44. PORTER, R.J., WOLF, A.A. Jr. & PENRY, J.K. (1971). Human electroencephalographic telemetry. A review of systems and their applications and a new receiving system. Am. J. EEG. Technoi, 11,145–159.Google Scholar
  45. QUY, R.J. (1978). A miniature preamplifier for ambulatory monitoring of the electroencephalogram. J. Physiol. (Lond.), 284,23–24.Google Scholar
  46. QUY, R.J., FITCH, P. & WILLISON, R.G. (1980). High speed automatic analysis of EEG spike and wave activity using an analogue detection and microcomputer plotting system. Electroencephalogr. clin. Neurophysiol., 49, 187–189.PubMedCrossRefGoogle Scholar
  47. QUY, R.J., WILLISON, R.G., FITCH, P. & GILLIATT, R.W. (1980). Some developments in ambulatory monitoring of the EEG. In ISAM 1979: Proceedings of the Third International Symposium on Ambulatory Monitoring, eds Stott, F.D., Raftery, E.B., Sleight, P. & Goulding, L. pp. 393–398. London: Academic Press.Google Scholar
  48. REILLEY, E.L. & PETERS, J.F. (1973). Relationship of some varieties of electroencephalographic photosensitivity to clinical convulsive disorders. Neurology (Minneap.), 23, 1050–1057.CrossRefGoogle Scholar
  49. RICHENS, A. (1975). Clinical pharmacology and medical treatment. In A Textbook of Epilepsy, eds Laidlaw, J. & Richens, A. London and Edinburgh: Churchill Livingstone.Google Scholar
  50. RICHENS, A. (1976). Drug Treatment of Epilepsy. London: Henry Kimpton.Google Scholar
  51. RICHENS, A. & AHMAD, S. (1975). A controlled trial of sodium valproate in severe major epilepsy. Br. med. J., 4, 255–256.PubMedPubMedCentralCrossRefGoogle Scholar
  52. RODIN, E., RIM, C. & RENNICK, P. (1974). The effects ofcarbamazepine on patients with psychomotor epilepsy: Results of a double-blind study. Epilepsia, 15, 547–561.PubMedCrossRefGoogle Scholar
  53. ROWAN, A.J., BINNIE, C.D., de BEER-PAWLIKOWSKI, N.K.B., GOEDHART, D.M., GUTTER, T.L., VAN PARIJS, J.A.P., MEINARDI, H. & MEIJER, J.W.A. (1978). 24 hour EEG studies with very frequent antiepileptic drug concentration determinations in the study of sodium valproate. In Advances in Epileptology 1977, eds Meinardi, H. & Rowan, A.J. Amsterdam and Lisse: Swets and Zeitlinger.Google Scholar
  54. ROWAN, A.J., BINNIE, C.D., WARFIELD, C.A., MEINARDI, H. & MEIJER, J.W.A. (1979). The delayed effect of sodium valproate on the photoconvulsive response in man. Epilepsia, 20, 61–68.PubMedCrossRefGoogle Scholar
  55. ROWAN, A.J., PIPPENGER, C.E., McGREGOR, P.A. & FRENCH, J. (1975). Seizure activity and anticonvulsant drug concentration. Arch. Neurol, 32, 281–288.PubMedCrossRefGoogle Scholar
  56. SATO, S., PENRY, J.K. & DREIFUSS, F.E. (1976). Electro-encephalographic monitoring of generalised spike-wave paroxysms in the hospital and at home. In Quantitative Analytic Studies in Epilepsy, eds Kellerway, P. & Petersen, I., pp. 237–251. New York: Raven Press.Google Scholar
  57. SHORVON, S.D., CHADWICK, D., GALBRAITH, A.W. & REYNOLDS, E.H. (1978). One drug for epilepsy. Br. med. J., 1, 474–476.PubMedPubMedCentralCrossRefGoogle Scholar
  58. WADA, J.A., TERAO, A. & BOOKER, H.E. (1972). Longitudinal correlative analysis of epileptic baboon, Papio papio. Neurology (Minneap.), 22, 1272–1285.CrossRefGoogle Scholar
  59. WHITE, P.T., PLOTT, D. & NORTON, J. (1966). Relative anticonvulant potency of primidone. A double-blind comparison. Arch. Neurol. (Chic), 14, 31–35.CrossRefGoogle Scholar
  60. WILKUS, R.J. & DODRILL, C.B. (1976). Neuropsychological correlates of the electroencephalogram in epileptics: 1, topographic distribution. Epilepsia, 17, 89–100.PubMedCrossRefGoogle Scholar
  61. WILKUS, R.J., DODRILL, C.B. & TROUPIN, A.S. (1978). Carbamazepine and the electroencephalogram of epileptics: a double-blind study in comparison to Phenytoin. Epilepsia, 19,283–291.PubMedCrossRefGoogle Scholar
  62. YAMAMOTO, J., FURAYA, E., WAKAMATSU, H. & HISHIKAWA, Y. (1971). Modification of photosensitivity in epileptics during sleep. Electroencephalogr. clin. Neurophysiol., 31, 509–513.PubMedCrossRefGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 1981

Authors and Affiliations

  • Norman Milligan
    • 1
  • Alan Richens
    • 1
  1. 1.Clinical Pharmacology UnitInstitute of NeurologyLondonUK

Personalised recommendations